CHRISTOPHER BASS: Open Payments
NPI 1831185057 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,137 in 138 payments from 22 companies in 2025. Trend: 2023 $2,995 · 2024 $3,321 · 2025 $3,137
Food & beverage: $2,876Education: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $455 |
| Janssen Biotech, Inc. | 14 | $383 |
| Regeneron Healthcare Solutions, Inc. | 10 | $316 |
| GENZYME CORPORATION | 8 | $279 |
| Arcutis Biotherapeutics, Inc. | 7 | $237 |
| E.R. Squibb & Sons, L.L.C. | 14 | $189 |
| UCB, Inc. | 16 | $184 |
| Lilly USA, LLC | 8 | $164 |
| Incyte Corporation | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Zoryve, Sotyktu, RINVOQ, Bimzelx, TALTZ.
Industry payments across GA — which companies pay providers there.
